The present disclosure provides for a primer designing technique for amplification of templates with unpredicted sequence variations. A major hurdle in designing primers for amplifications from microbial genomes is the presence of mutations, also called Single Nucleotide Polymorphisms (SNPs) among the microbial stra...
The thermo-stable PCR enzyme, Taq DNA Polymerase of the instant disclosure is a genetically engineered enzyme modified by site-directed random mutagenesis protocol.The instant mutant could amplify 500 bp DNA fragments within 1 sec polymerization time and 1 Kb DNA fragment within 2 seconds. Further, the denaturation ...
[Class : 5] Enzymes Preparation For Medical And Veterinary Purpose
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Enzymes Preparation For Medical And Veterinary Purpose
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Enzymes Preparation For Medical And Veterinary Purpose
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
View +8 more Brands for Chromous Biotech Private Limited.
Charges
2 Crore
28 March 2019
Corporation Bank
45 Lak
25 April 2012
Department Of Biotechnology
43 Lak
01 March 2012
Department Of Biotechnology
1 Crore
30 December 2008
Corporation Bank
1 Crore
28 March 2019
Others
0
01 March 2012
Department Of Biotechnology
0
25 April 2012
Department Of Biotechnology
0
30 December 2008
Corporation Bank
0
28 March 2019
Others
0
01 March 2012
Department Of Biotechnology
0
25 April 2012
Department Of Biotechnology
0
30 December 2008
Corporation Bank
0
Documents
Form DPT-3-22052020-signed
Form DPT-3-17012020-signed
Form AOC-4-14122019_signed
Form MGT-7-10122019_signed
Optional Attachment-(1)-30112019
Directors report as per section 134(3)-30112019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-30112019
List of share holders, debenture holders;-30112019
Letter of the charge holder stating that the amount has been satisfied-19062019
Instrument(s) of creation or modification of charge;-19062019
Form CHG-4-19062019_signed
Form CHG-1-19062019_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20190619
CERTIFICATE OF SATISFACTION OF CHARGE-20190619
List of share holders, debenture holders;-29122018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29122018
Directors report as per section 134(3)-29122018
Form MGT-7-29122018_signed
Form AOC-4-29122018_signed
Form MGT-14-18072018_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-18072018
Optional Attachment-(2)-18072018
Optional Attachment-(1)-18072018
Notice of resignation;-18072018
Form DIR-12-18072018_signed
Evidence of cessation;-18072018
Declaration of the appointee director, Managing director, in Form No. DIR-2;-18072018